ESR1 binding sites were significantly enriched for DNaseI hypersensitivity peaks drawn from multiple cell types (Ecc-1, Ishikawa, MDF-7, T47D, LNCaP, HUVEC, glioma and Th1 CD4+, Additional file 1: Table S8). This evidence concerns the gene CD4 and central nervous system cancer.